United States Court of Federal Claims, 2015

Choksi v. Secretary of Health and Human Services

United States Court of Federal Claims · Decided September 8, 2015 · Thomas L. Gowen

Opinion

In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS No. 14-641V

Filed: August 18, 2015

(Unpublished)

**************************** DIPAK CHOKSI, *

Petitioner, *

v. * Stipulation; Tdap; GBS

SECRETARY OF HEALTH * AND HUMAN SERVICES, *

Respondent. *

**************************** Amber Wilson, Esq., Maglio, Christopher and Toale, PA, Washington, DC, for petitioner. Darryl Wishard, Esq., U.S. Dep’t. of Justice, Washington, DC, for respondent.

DECISION ON JOINT STIPULATION1

Gowen, Special Master:

Dipak Choksi [“petitioner”] filed a petition for compensation under the National Vaccine Injury Compensation Program2 on July 22, 2014. Petitioner alleges that he suffered from Guillain-Barre syndrome [GBS] that was caused in fact by the Tdap vaccine he received on July 14, 2013. See Stipulation, filed Aug. 18, 2015, at ¶¶ 2, 4. Further, petitioner alleges that he experienced residual effects of his injuries for more than six months. Stipulation at ¶ 4. Respondent denies that the Tdap vaccine either caused or significantly aggravated petitioner’s alleged injuries or any other injury, and denies that petitioner’s current disabilities are the result of a vaccine-related injury. Stipulation at ¶ 6.

Nevertheless, the parties have agreed to settle the case. On August 18, 2015, the parties filed a joint stipulation agreeing to settle this case and describing the settlement terms.

Respondent agrees to pay petitioner: a. A lump sum of $375,250.00 in the form of a check payable to petitioner,

Dipak Choksi. This amount represents compensation for all damages that would be available under § 300aa-15(a).

The special master adopts the parties’ stipulation attached hereto, and awards compensation in the amount and on the terms set forth therein. The clerk of the court is directed to enter judgment in accordance with this decision.3 IT IS SO ORDERED. s/ Thomas L. Gowen Thomas L. Gowen Special Master

1 Because this unpublished decision contains a reasoned explanation for the action in this case, I intend to post this decision on the United States Court of Federal Claims' website, in accordance with the E- Government Act of 2002, Pub. L. No. 107-347, § 205, 116 Stat. 2899, 2913 (codified as amended at 44 U.S.C. § 3501 note (2006)). In accordance with Vaccine Rule 18(b), a party has 14 days to identify and move to delete medical or other information, that satisfies the criteria in 42 U.S.C. § 300aa-12(d)(4)(B). Further, consistent with the rule requirement, a motion for redaction must include a proposed redacted decision. If, upon review, I agree that the identified material fits within the requirements of that provision, I will delete such material from public access. 2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012). 3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by each party filing a notice renouncing the right to seek review.

Case-law data current through September 30, 2026. Source: CourtListener bulk data.